Structures by: Whittaker G.
Total: 12
Aspirin
C9H8O4
Faraday Discussions (2003) 122, 363
a=11.233(3)Å b=6.5440(10)Å c=11.231(3)Å
α=90.00° β=95.89(2)° γ=90.00°
Aspirin
C9H8O4
Faraday Discussions (2003) 122, 363
a=11.233(3)Å b=6.5440(10)Å c=11.231(3)Å
α=90.00° β=95.89(2)° γ=90.00°
Aspirin
C9H8O4
Faraday Discussions (2003) 122, 363
a=11.233(3)Å b=6.5440(10)Å c=11.231(3)Å
α=90.00° β=95.89(2)° γ=90.00°
Aspirin
C9H8O4
Faraday Discussions (2003) 122, 363
a=11.233(3)Å b=6.5440(10)Å c=11.231(3)Å
α=90.00° β=95.89(2)° γ=90.00°
[Cu(L)2].4DMF
[Cu(L)2].4DMF
Chemical Communications (2001) 18 1824
a=29.090(2)Å b=13.2462(9)Å c=18.6300(10)Å
α=90.00° β=112.5060(10)° γ=90.00°
[Cu(L)2][BF4].2CH2Cl2
[Cu(L)2][BF4].2CH2Cl2
Chemical Communications (2001) 18 1824
a=12.6062(7)Å b=18.2942(10)Å c=25.5061(14)Å
α=90.00° β=96.191(1)° γ=90.00°
LH.1Me2CO
C29H32N2O,C3H6O
Dalton Transactions (2003) 10 1975
a=18.059(2)Å b=8.5608(9)Å c=19.135(2)Å
α=90.00° β=106.566(2)° γ=90.00°
(CuL2).3MeOH
C61H74CuN4O5
Dalton Transactions (2003) 10 1975
a=12.207(1)Å b=13.790(1)Å c=18.805(2)Å
α=70.972(2)° β=74.630(2)° γ=68.125(2)°
(ZnL2).2.5MeCN.0.3CH2Cl2
ZnC58H62O2N4,2.5(C2H3N),0.3(CH2Cl2)
Dalton Transactions (2003) 10 1975
a=16.9519(9)Å b=17.8270(9)Å c=19.2760(10)Å
α=90.00° β=102.088(1)° γ=90.00°
(ZnL2)(BF4).2CH2Cl2.0.75pentane
C62.5H70.25BCl4F4N4O2Zn
Dalton Transactions (2003) 10 1975
a=13.964(4)Å b=17.079(5)Å c=28.310(9)Å
α=90.00° β=91.729(6)° γ=90.00°
C18H18N5NiS3,BF4
C18H18N5NiS3,BF4
J. Chem. Soc., Dalton Trans. (2002) 23 4389-4394
a=7.2069(6)Å b=11.0525(8)Å c=14.0537(8)Å
α=104.688(7)° β=95.563(9)° γ=100.377(11)°
C36H36FN4Ni2S63,3(BF4),C2H3N,H2O
C36H36FN4Ni2S63,3(BF4),C2H3N,H2O
J. Chem. Soc., Dalton Trans. (2002) 23 4389-4394
a=12.471(5)Å b=12.777(3)Å c=15.590(2)Å
α=96.16(2)° β=97.46(2)° γ=107.63(2)°